PPT-Venous Thromboembolic Disease: The Role of Novel Anticoagulants

Grant M Greenberg MD MA MHSA Overview Identify the challenges in diagnosis of Venous Thromboembolic Disease   Diagram current protocolspathways for evaluation and treatment of VTE Review current anticoagulation . Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. Research Advisory Committee. David . Kratville. Senior Environmental Scientist. CDFA – Integrated Pest Control Branch. Vertebrate Pests. Purpose of this training. Overview of rodenticides. History of VPCRAC. The Challenge of Edema. S. . Lakhanpal . MD, FACS. President & CEO. Center for Vein Restoration. Case Presentation. 67 year old male. Presents with Left Calf . Ulceration. Duration. : 2 months. Associated . Update: November 2016. . Steven E. Zimmet, MD . RPVI RVT FACPh. President, ABVLM. Disclosures. President, ABVLM. Overview. Background: VLM. Testing of Foundation Knowledge: ABMS specialties. ABVLM . Northlakes. Community Clinic. Minong, WI. Novel Anticoagulants:. Who Needs an INR Anymore?. Apixaban. (. Eliquis. ):. Approved in 2014. Rivaroxaban. (. Xarelto. ):. Approved in 2011. Dabigatran. (. . A Comprehensive Review . Assessment & Management . 1. 2015 AXXESS. UNAUTHORIZED USE IS PROHIBITED. Objectives. 2. Understand Arterial & Venous disease. Understand the etiology of . . lower extremities ulcers. Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. HHHoldorf. Venous physiology and Hemodynamics. Venous Resistance. Peripheral venous and arterial resistances are similar. Both arteries and veins carry same amount of blood. This Paradox is explained by the “collapsible” nature of the venous wall.. Evidence base and expert opinion put into practice. Christine Herb, . MS, FNP-C, CWON. Syracuse VA Medical Center. June 13, 2014. Venous. vs.. . Arterial. . vs. . Neuropathic. 1. st. it is critical to correctly determine the etiology!. What are Direct-Acting Oral Anticoagulants DOACsANSWERS by heartTreatments TestscontinuedAdhere to your medication regimen and do not abruptly stop taking your DOACs without 31rst talking with your d S. DR USMAN QURESHI. SURGICAL UNIT-1. 2. presentation outlines. Intoduction. Venous and lymphatic drainage of extermities.. Pathophysiology and Mx of specific venous diseases.. .Varicose vein. DVT removal and venous stenting This leaflet explains whatdeep vein thrombosis (DVT) removal and venous It is not meant to replace informed discussion between you and your doctor but can act as a sta existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo Thromboembolism. Jatheesh mohan. BACKGROUND. Factor . XIa. inhibitors for the prevention and treatment of venous and arterial thromboembolism may be more effective and result in less bleeding than conventional anticoagulants..